Lyra Therapeutics (LYRA) Return on Capital Employed Growth (1y) (2021 - 2025)
Lyra Therapeutics (LYRA) Return on Capital Employed Growth (1y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 45.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -785.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1,629.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 3,193.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -28.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 399.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -310.00 |
| 10 | Lyra Therapeutics | 70,995.28 | 70,995.28 | - | 5,870.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5,870.00 |
| Sep 30, 2025 | 5,008.00 |
| Jun 30, 2025 | 1,119.00 |
| Mar 31, 2025 | -10,433.00 |
| Dec 31, 2024 | -10,086.00 |
| Sep 30, 2024 | -7,808.00 |
| Jun 30, 2024 | -4,042.00 |
| Mar 31, 2024 | 1,084.00 |
| Dec 31, 2023 | -377.00 |
| Sep 30, 2023 | -1,404.00 |
| Jun 30, 2023 | -132.00 |
| Mar 31, 2023 | 9,342.00 |
| Dec 31, 2022 | 4,510.00 |
| Sep 30, 2022 | 1,893.00 |
| Jun 30, 2022 | -1,835.00 |
| Mar 31, 2022 | -12,824.00 |
| Dec 31, 2021 | -7,323.00 |
| Sep 30, 2021 | -4,532.00 |
| Jun 30, 2021 | -1,930.00 |
| Mar 31, 2021 | 4,002.00 |